Misoprostol For Nulliparous Women Before Hysteroscopy
Status:
Unknown status
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
To compare the impact of 400-microgram self-administered vaginal versus self-administered
oral misoprostol at home on preoperative cervical ripening in nulliparous women prior to
outpatient hysteroscopy.